麻豆影视

Skip to main content

There's still no standard test to detect pancreatic cancer early. Scientists are working to change that

Pancreatic cancer cells, shown in blue, can be difficult to detect in early stages of the disease, and there is no single test that can tell you if you have pancreatic cancer early. (From the National Cancer Institute via CNN Newsource) Pancreatic cancer cells, shown in blue, can be difficult to detect in early stages of the disease, and there is no single test that can tell you if you have pancreatic cancer early. (From the National Cancer Institute via CNN Newsource)
Share

To spot breast cancer early, there are mammograms. To find colon cancer early, there are colonoscopies. But there is no standard test to detect early cases of pancreatic cancer, before cancer cells have spread and when surgery is more likely to be helpful.

Finding pancreatic cancer early could help increase a patient鈥檚 chances of survival. Although pancreatic accounts for just about 3% of all new cancer cases in the United States, it鈥檚 the third leading cause of cancer deaths and is projected to become the second leading cause of cancer deaths by the end of this decade.

Across the United States, research teams are investigating ways to spot early cases, with many turning to blood-based liquid biopsy tests.

"This term 鈥榣iquid biopsy,鈥 essentially, is trying to find markers in the blood that signify a tumor is present 鈥 and there are many different ways to do that. There are a lot of different features of a tumor that can end up in the blood that you could use,鈥 said Dr. Brian Wolpin, director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, whose laboratory has done work in this area.

But many studies investigating the potential of liquid biopsy tests for the early detection of pancreatic cancer are still in the early phases. And the US Preventive Services Task Force recommends against screening for pancreatic cancer in adults who are not showing symptoms, especially because there is no established method or test to detect this form of the disease early in the general population.

Although there currently is no single recommended blood test to find early pancreatic cancers, 鈥渢here is a large scientific community working to try to change this and to identify a screening test that we can use in the clinic, but it鈥檚 quite hard,鈥 Wolpin said. 鈥淭here鈥檚 still more work that needs to be done to get there.鈥

One team presented its research Monday at an annual meeting of the American Association for Cancer Research, detailing the development of a liquid biopsy test that was found to detect 97% of stage I and stage II pancreatic cancers in hundreds of volunteers. The researchers are from the City of Hope Comprehensive Cancer Center and other institutions around the world.

Their study, which has not been published in a peer-reviewed journal, included 984 people, some healthy and others with pancreatic cancer, based in Japan, the United States, South Korea and China.

The researchers collected blood samples from each person and tested the expression of a set of small genes called microRNAs within the blood and encapsulated within exosomes found in the blood. Exosomes are small vesicles that are shed by both cancerous and healthy cells in the blood.

鈥淐ancer cells tend to release many, many more exosomes compared to our healthy cells because our healthy cells do not multiply as fast as cancer cells do,鈥 said Dr. Ajay Goel, senior author of the study and the chair of the Department of Molecular Diagnostics and Experimental Therapeutics at City of Hope. 鈥淎nd once these exosomes are released by the tumor cells, they circulate in our bloodstream.鈥

Goel and his colleagues identified eight microRNAs found in exosomes that are shed by cancerous cells in the pancreas and five microRNAs in blood. They used those markers to develop an approach for determining whether a person鈥檚 exosomes are associated with pancreatic cancer.

The researchers found that their liquid biopsy approach detected 93% of pancreatic cancers among the US volunteers in their study, 91% of pancreatic cancers in the South Korean cohort and 88% of pancreatic cancers in the Chinese cohort.

The researchers ran their tests again and, this time, not only used their exosome-based markers but also tested for a key protein called CA19-9, known to be associated with pancreatic cancer. When they combined their approach with CA19-9 testing, they were able to accurately detect 97% of stage I and stage II pancreatic cancers in the US volunteers.

鈥淭hat鈥檚 what we are excited about: that not only this test worked beautifully in all stages, but it is 97% accurate in finding those who have either stage I or stage II disease,鈥 Goel said.

He added that the test presented false positive results for stage I and II pancreatic cancers at a rate of less than 5%, the study data showed.

鈥淚t鈥檚 very important to diagnose the disease at the earliest possible stage, like stage I or II disease, which means there is a higher chance that the cancer is operable surgically,鈥 Goel said. 鈥淭he best cure for a pancreas patient is not chemotherapy or drugs but to take the cancer out.鈥

Surgeons may be 鈥渧ery reluctant鈥 to operate when someone has stage III or IV pancreatic cancer, he said. That鈥檚 sometimes because of the complexity of such a procedure, the long-term complications and the likelihood that surgery at that advanced stage may not be enough to prevent the cancer from coming back.

鈥淭hat鈥檚 why it is very important that this blood test is so good that it can, 97% of the time, find the cancers at the earliest possible stages where we can intercept the cancer, where we can intervene, and we can surgically remove this cancer effectively,鈥 Goel said.

'We need to do something'

There are blood-based tests for pancreatic cancer that are used in medicine, but they鈥檙e often used in people who have already been diagnosed with the disease. Doctors might repeat blood tests during and after treatment to determine how the cancer is responding. But there is no blood test that can detect early pancreatic cancer.

Goel and his colleagues wrote in their abstract that their approach 鈥渃an potentially be further validated for clinical use in the near future,鈥 specifically for the early detection of pancreatic cancer.

鈥淲e were generally excited about these particular data, because the cancer type we鈥檙e looking at here is extremely lethal,鈥 Goel said.

鈥淭he number of people who are going to be affected with this disease or this cancer is going to continue to go up,鈥 he said. 鈥淪o we need to do something about it, and that is why we were extremely excited that we have a blood-based liquid biopsy for early detection of pancreatic cancer with this high sensitivity.鈥

The liquid biopsy test study that Goel and his colleagues presented is 鈥渋nteresting,鈥 Wolpin said, and describes one approach to possibly developing a test for early detection 鈥 where there is a big need.

Definitively diagnosing someone with pancreatic cancer can involve a series of scans, blood tests and biopsies, which are typically performed only once someone has symptoms, which may include jaundice or yellowing of the eyes and skin, weight loss, belly or back pain, or tiredness and weakness. But by that point, the cancer is probably advanced.

鈥淭he vast majority of patients who present with pancreatic cancer have advanced disease at the time of their diagnosis. So 80% or more of patients present with advanced disease where we know at the time of their presentation, we鈥檙e very unlikely to be able to cure the cancer,鈥 Wolpin said.

鈥淭hat鈥檚 very different than many other of the major cancer types like breast cancer or colorectal cancer, where the vast majority of patients actually present with early disease,鈥 he said. 鈥淭he symptoms from pancreatic cancer are generally less specific, like some abdominal discomfort or sometimes weight loss 鈥 things that often don鈥檛 immediately trigger people to go to their doctor.鈥

But some experts warn that mass testing of average-risk healthy people who are not showing symptoms could lead to false positive results, doing more harm than good.

'The pancreas is a very weird organ'

The City of Hope researchers are not the only scientists hoping to develop a reliable test to diagnose pancreatic cancer patients as early as possible.

In 2020, found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease.

In 2022, at UC San Diego and other institutions found that a blood test to detect proteins associated with cancer cells was able to identify 95.5% of stage I pancreatic cancers among a sample of more than 300 volunteers, among whom 139 were cancer patients and 184 were healthy people.

In general, the field of pancreatic cancer is an area where there has not been much advancement when it comes to either early-stage or advanced disease, said Dr. Al Neugut, a medical oncologist at Columbia University鈥檚 Herbert Irving Comprehensive Cancer Center and professor of epidemiology at Columbia University Mailman School of Public Health, who was not involved in any of the liquid biopsy testing research.

鈥淧ancreatic cancer is the poster child for cancers we鈥檝e gotten nowhere with,鈥 Neugut said.

鈥淭he pancreas is a very weird organ, and it鈥檚 just different than every other organ in the body,鈥 he said. 鈥淚t鈥檚 behind the abdomen, so it鈥檚 hard to get to. It鈥檚 not easy for a surgeon. It鈥檚 not easy for an oncologist. It makes it very difficult even to approach. You can鈥檛 examine it physically. It鈥檚 hard to get to radiologically. It鈥檚 hidden.鈥

Although pancreatic cancer is rare, people can lower their risk by eating a healthy diet, maintaining a healthy weight, getting regular exercise, avoiding alcohol, limiting exposures to carcinogens and not smoking.

鈥淪moking is the most important avoidable risk factor for pancreatic cancer,鈥 according to the American Cancer Society.

Still, having some form of test to detect pancreatic cancer early would 鈥渄ramatically change the landscape鈥 for patients, Wolpin said, adding that he hopes the medical field can achieve developing such a tool.

鈥淭he more patients we can find early, the greater the chance we have to cure patients of pancreatic cancer and start to reverse the statistics that are pretty tough 鈥 almost 90% of patients who get pancreatic cancer die from their cancer,鈥 Wolpin said. 鈥淲e really need to change those numbers, and finding the cancer earlier would be a dramatic way to do that.鈥

CTVNews.ca Top Stories

The British Columbia election campaign is set to officially start today, with Lt.-Gov. Janet Austin issuing the writ for the Oct. 19 vote.

A northern Ontario man is facing a $12,000 fine after illegally shooting a moose near the Batchawan River.

Unusual flippered feet are making their way into the Saint Lawrence River this weekend. Led by underwater explorer and filmmaker Nathalie Lasselin, volunteer divers are combing the riverbed near Beauharnois in Mont茅r茅gie to remove hundreds of tires that have been polluting the aquatic environment for decades.

A sea lion swam free after a rescue team disentangled it near Vancouver Island earlier this week.

Local Spotlight

Cole Haas is more than just an avid fan of the F.W. Johnson Wildcats football team. He's a fixture on the sidelines, a source of encouragement, and a beloved member of the team.

Getting a photograph of a rainbow? Common. Getting a photo of a lightning strike? Rare. Getting a photo of both at the same time? Extremely rare, but it happened to a Manitoba photographer this week.

An anonymous business owner paid off the mortgage for a New Brunswick not-for-profit.

They say a dog is a man鈥檚 best friend. In the case of Darren Cropper, from Bonfield, Ont., his three-year-old Siberian husky and golden retriever mix named Bear literally saved his life.

A growing group of brides and wedding photographers from across the province say they have been taken for tens of thousands of dollars by a Barrie, Ont. wedding photographer.

Paleontologists from the Royal B.C. Museum have uncovered "a trove of extraordinary fossils" high in the mountains of northern B.C., the museum announced Thursday.

The search for a missing ancient 28-year-old chocolate donkey ended with a tragic discovery Wednesday.

The Royal Canadian Mounted Police is celebrating an important milestone in the organization's history: 50 years since the first women joined the force.

It's been a whirlwind of joyful events for a northern Ontario couple who just welcomed a baby into their family and won the $70 million Lotto Max jackpot last month.